Strata Critical Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021
Revenue	268.62	248.69	225.18	146.12	67.16	50.53
Revenue Growth (YoY)	70.11%	10.44%	54.11%	117.58%	32.92%	115.61%
Cost of Revenue	204.82	189.77	183.06	123.85	54.31	40.01
Gross Profit	63.8	58.92	42.12	22.28	12.85	10.52
Selling, General & Admin	85.59	82.42	82.18	67.23	42.96	32.66
Research & Development	3.51	3.18	4.63	5.55	2.16	1.68
Operating Expenses	89.1	85.61	86.8	72.77	45.11	34.34
Operating Income	-25.3	-26.69	-44.68	-50.5	-32.26	-23.82
Interest & Investment Income	5.19	7.21	8.44	3.43	0.74	0.46
Other Non Operating Income (Expenses)	-0.25	-0.85	2.13	24.23	-9.15	-20.06
EBT Excluding Unusual Items	-20.36	-20.33	-34.11	-22.84	-40.67	-43.42
Merger & Restructuring Charges	-2.64	-1.48	-	-3.03	-	-0.27
Gain (Loss) on Sale of Investments	-5.2	-	0.01	-2.16	-	-
Asset Writedown	-	-5.76	-20.75	-	-	-
Other Unusual Items	-	-	-2.68	-	-	-
Pretax Income	-33.51	-27.56	-57.54	-28.03	-40.67	-43.7
Income Tax Expense	-0.26	-0.26	-1.47	-0.77	-3.75	-3.64
Net Income	40.39	-27.31	-56.08	-27.26	-36.92	-40.05
Preferred Dividends & Other Adjustments	-	-	-	-	0.02	-
Net Income to Common	40.39	-27.31	-56.08	-27.26	-36.94	-40.05
Shares Outstanding (Basic)	81	77	74	71	54	43
Shares Outstanding (Diluted)	81	77	74	71	54	43
Shares Change (YoY)	5.22%	5.41%	3.21%	31.65%	26.18%	70.10%
EPS (Basic)	0.50	-0.35	-0.76	-0.38	-0.68	-0.93
EPS (Diluted)	0.50	-0.35	-0.76	-0.38	-0.68	-0.93
Free Cash Flow	-54.7	-33.39	-34.46	-37.86	-22.12	-15.91
Free Cash Flow Per Share	-0.68	-0.43	-0.47	-0.53	-0.41	-0.37
Gross Margin	23.75%	23.69%	18.71%	15.24%	19.14%	20.82%
Operating Margin	-9.42%	-10.73%	-19.84%	-34.56%	-48.04%	-47.15%
Profit Margin	15.04%	-10.98%	-24.90%	-18.66%	-55.00%	-79.27%
Free Cash Flow Margin	-20.36%	-13.43%	-15.30%	-25.91%	-32.93%	-31.49%
EBITDA	-17.63	-20.73	-37.57	-44.77	-31.09	-23.23
EBITDA Margin	-6.56%	-8.33%	-16.68%	-30.64%	-46.29%	-45.97%
D&A For EBITDA	7.67	5.96	7.11	5.73	1.17	0.6
EBIT	-25.3	-26.69	-44.68	-50.5	-32.26	-23.82
EBIT Margin	-9.42%	-10.73%	-19.84%	-34.56%	-48.04%	-47.15%
Advertising Expenses	-	2.71	4.06	4.54	-	1.89

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q